The Healthy Eating and Active Living to Reverse Diabetes Pilot Study
HEAL Diabetes
Healthy Eating and Active Living to Reverse Diabetes Pilot Study
2 other identifiers
interventional
35
1 country
2
Brief Summary
The HEAL Diabetes Program is a multicomponent intensive plant-forward healthy eating program designed to reverse diabetes. Several recent studies, most notably the Diabetes UK-funded Diabetes Remission Clinical Trial (DiRECT) in England and Scotland, have demonstrated that intensive programs for weight loss and weight loss maintenance can lead to long-term remission of diabetes for as many as half of patients with early Type 2 (adult-onset) diabetes. Furthermore, the U.S. Preventive Services Task Force has recommended that all patients with obesity and at highest risk for diabetes be referred to such intensive multicomponent behavioral weight loss interventions, but no such programs are available for people living in the low-income and underserved areas of Memphis. This effort will pilot an innovative, culturally tailored, and intensive healthy eating program designed to reverse diabetes based in the UTHSC Neighborhood Health Hub located in low-income neighborhoods to demonstrate that this approach will work in Memphis to improve and extend people's lives. The HEAL Diabetes Pilot Program will: a) engage and retain a minimum of 30 patients with Type 2 diabetes and obesity to participate in the program as well as 30 additional "control" patients who will receive routine care, and b) assess patient outcomes including weight loss and rates of diabetes remission using average blood sugar (hemoglobin A1c) over a six-month period. The healthy eating and active living to reverse diabetes (HEAL Diabetes) is a pilot study that aims to evaluate the feasibility, effectiveness, and operational and financial sustainability of a multicomponent health coach-supported nutrition intervention in a predominately African American population in Memphis, Tennessee. The investigators aim to assess study feasibility by evaluating recruitment, sample characteristics, intervention acceptability and procedural suitability. The investigators also aim to quantify and compare the treatment and control groups on primary outcomes including changes in body weight, hemoglobin A1c (HbA1c), and proportion of patients who achieved diabetes remission (HbA1c25 \< 6.5%) from baseline to 12-months. Additionally, the investigators aim to assess changes in diabetes self-efficacy and self-care activities and examine cost effectiveness of the multicomponent intervention. Drawing on evidence from DiRECT, MODEL, and related studies, the investigators hypothesize that the intervention arm will achieve greater weight loss and higher diabetes remission than the control. Additionally, the investigators hypothesize that the program will be operationally and financially sustainable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2025
CompletedFirst Submitted
Initial submission to the registry
December 2, 2025
CompletedFirst Posted
Study publicly available on registry
January 5, 2026
CompletedJanuary 5, 2026
December 1, 2025
1.8 years
December 2, 2025
December 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Body Weight
Change in body weight in pounds from baseline to 6 months
From enrollment to the end of 6 months.
Change in Hemoglobin A1c (HbA1c)
Change in HbA1c (%) from baseline to 6 months
Baseline to 6 months
Proportion of Participants Achieving Diabetes Remission
Proportion of participants achieving diabetes remission at 6 months, defined as HbA1c \< 6.5% without use of glucose-lowering medications for at least 2 months
6 months
Secondary Outcomes (4)
Change in Random Blood Glucose
Baseline to 6 months
Change in Diabetes Self-Efficacy Score
Baseline to 6 months
Change in Diabetes Self-Care Activities Score
Baseline to 6 months
Cost of Intervention Delivery
6 months
Study Arms (2)
Enhanced Care
ACTIVE COMPARATORParticipants in this arm received enhanced usual care only. Enhanced usual care consisted of standard diabetes education, health coaching, and routine clinical management provided by their existing healthcare providers. No additional study-delivered classes, coaching, or materials were provided. Participants completed study assessments on the same schedule as the intervention group.
Intensive Care (Multicomponent Intervention)
EXPERIMENTALParticipants in this arm received a structured, multicomponent diabetes remission intervention promoting healthy eating and intensive weight loss in addition to usual care. The intervention included biweekly group sessions over the study period, covering nutrition and weight management; cooking classes; individual health coaching; 3-month diet replacement; and physician-supervised medication discontinuation. The program also included goal-setting, progress check-ins, and supportive accountability delivered by health coaches. Participants completed the same study assessments as the enhanced care arm.
Interventions
An intensive multicomponent diet and weight-loss intervention designed to support diabetes remission. The program included biweekly group sessions focused on low-carbohydrate, moderate-fat nutrition strategies; portion and calorie guidance; behavior-change skills; goal-setting; and weight-tracking. Participants also completed biweekly individual health-coaching sessions that provided personalized dietary guidance, problem-solving support, and adherence monitoring. The intervention incorporated 12 weeks of weekly total diet replacement provided through home delivery of lower-carbohydrate, lean-protein food items to facilitate adherence to dietary goals. During the total diet replacement phase participants also received physician-supervised medication discontinuation. Physical activity recommendations and strategies for managing blood glucose were also covered. The intervention was delivered by health coaches and provided in addition to participants' usual clinical care.
Participants received enhanced usual diabetes care. This included optional diabetes self-management education provided through routine clinic services, individualized health-coaching sessions provided at neighborhood health hub facilities focused on general diabetes management support. In addition, participants received four produce vouchers valued at $50 each to promote access to fresh fruits and vegetables. No additional study-delivered classes, dietary programming, or supplemental food items were provided.
Eligibility Criteria
You may qualify if:
- adults 18 years or older
- a type 2 diabetes (T2D) duration of 0-6 years (diagnosis based on one recorded HbA1c test)
- HbA1c value ≥ 6.5 percent at the screening visit
- BMI ≥ 25 kg/m2
- access to a cell phone or smartphone with texting and voicemail capabilities
You may not qualify if:
- current use of insulin or more than two hypoglycemic medications (either oral or injectable)
- a recent routine HbA1c greater than or equal to 12%
- weight loss of \>5 kg within the last six months
- inability to understand consent procedures, understand and speak English
- pregnancy or considering pregnancy
- diagnosis or exhibited unstable psychiatric condition, dementia, neurological disorder, or history of severe head trauma or brain tumor, and cognitive impairment
- perceived unwillingness or inability to participate
- planned move from the region during the study
- participation in another clinical research trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
UTHSC Health Hub-Uptown
Memphis, Tennessee, 38105, United States
UTHSC Health Hub-ShelbyCares
Memphis, Tennessee, 38109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Director, Tennessee Population Health Consortium
Study Record Dates
First Submitted
December 2, 2025
First Posted
January 5, 2026
Study Start
October 11, 2023
Primary Completion
August 2, 2025
Study Completion
August 2, 2025
Last Updated
January 5, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the dataset contains sensitive, identifiable health information, and sharing could compromise participant privacy. Data are intended for use only by the study team for the purposes outlined in the study protocol.